Learning Objectives

1. Describe how developing and characterizing model systems for lung squamous cell carcinoma (LSCC) is key to understanding LSCC preinvasive disease and tumorigenesis. 

2.  Discuss how local immune microenvironment may contribute to the progression of premalignancy in early LSCC. 

3. Identify the contribution of the immune system to LSCC tumorigenesis and how it may allow for development of immunomodulatory cancer intervention strategies. 

 

Tachiro Pichardo, presenter, has no relevant financial relationships to disclose.

Session date: 
07/27/2022 - 3:30pm to 4:00pm EDT
Location: 
Zoom
United States
See map: Google Maps
Add to calendar: 
  • 0.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.50 Participation
Please login or register to take this course.